Alpha-2B adrenoceptor polymorphism and peripheral vasoconstriction

Pharmacogenetics and Genomics

Volumn 15, Issue 5, 2005, Pages 357-363

  Talke, Pekka ^a   Stapelfeldt, Claudia ^a   Lobo, Errol ^a   Brown, Ronald ^a   Scheinin, Mika ^b   Snapir, Amir ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Adrenergic; Alpha; Dexmedetomidine; Human; Polymorphism; Receptors; Vascular smooth muscle; Vasoconstriction

Indexed keywords

ALPHA 2B ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AZEPEXOLE; CLONIDINE; DEXMEDETOMIDINE; MIDAZOLAM; MIVAZEROL; PROPOFOL; TALIPEXOLE; THIOPENTAL;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DNA POLYMORPHISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; GENE DELETION; GENERAL ANESTHESIA; GENOTYPE; HEART RATE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; PHOTOELECTRIC PLETHYSMOGRAPHY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION;

EID: 18744368473     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01213011-200505000-00012     Document Type: Article

References (18)

1. Talke P. Pharmacodynamics of alpha2-adrenoceptor agonists. Bailliere's Clin Anaesthesiol 2000;14:271-283.
2. Talke P, Lobo E, Brown R. Systemically administered alpha2-agonist- induced peripheral vasoconstriction in humans. Anesthesiology 2003; 99: 65-70.
3. Bylund DB, Regan JW, Faber JE, Hieble JP, Triggle CR, Ruffolo RR Jr. Vascular alpha-adrenoceptors: from the gene to the human. Can J Physiol Pharmacol 1995; 73:533-543.
4. Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, et al. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 1996; 273:803-805.
5. Small KM, Brown KM, Forbes SL, Liggett SB. Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 2001; 276:4917-4922.
6. Snapir A, Heinonen P, Tuomainen TP, Alhopuro P, Karvonen MK, Lakka TA, et al. An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol 2001; 37:1516-1522.
7. Snapir A, Mikkelsson J, Perola M, Penttila A, Scheinin M, Karhunen PJ. Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J Am Coll Cardiol 2003; 41:190-194.
8. Nellcor N. 200 Service Manual, Hayward, CA. 1989.
9. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 1988; 150:9-14.
10. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999; 54:146-165.
11. Baumgart D, Naber C, Haude M, Oldenburg O, Erbel R, Heusch G, et al. G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res 1999; 85:965-969.
12. Baumgart D, Haude M, Gorge G, Liu F, Ge J, Grosse-Eggebrecht C, et al. Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 1999; 99:2090-2097.
13. van Meel JC, de Jonge A, Timmermans PB, van Zwieten PA. Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat. J Pharmacol Exp Ther 1981; 219:760-767.
14. Talke PO, Caldwell JE, Richardson CA, Heier T. The effects of clonidine on human digital vasculature. Anesth Analg 2000; 91:793-797.
15. Flavahan NA, Cooke JP, Shepherd JT, Vanhoutte PM. Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs. J Pharmacol Exp Ther 1987; 241:361-365.
16. Gregorini L, Marco J, Farah B, Bernies M, Palombo C, Kozakova M, et al. Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 2002; 106: 2901-2907.
17. Gregorini L, Marco J, Kozakova M, Palombo C, Anguissola GB, Marco I, et al. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999; 99:482-490.
18. Chotani MA, Mitra S, Su BY, Flavahan S, Eid AH, Clark KR, et al. Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2004; 286:H59-H67.